NCT05700617RecruitingEarly phase 1
Cardiac Power Output in Cardiogenic Shock Patients
Myocardial Reserve in Advanced Heart Failure Patients
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
- Status (registry)
- Recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 5 (estimated)
- First submitted
- 1 Nov 2022
- Start date
- 6 Jul 2023
- Primary completion date
- Dec 2027
- Lead sponsor
- University of Chicago
- Diseases
- Heart failure
- NCT number
- NCT05700617
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 5
- From 6 Jul 2023 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent acute coronary syndrome
Other illness
- Severe, non-revascularized coronary artery disease
- History of significant ventricular arrhythmia without an ICD
Lab values
- eGFR \< 30 ml/min/1.73 m2
Age
- Age \< 18 years-old
Who the study is looking for
- LVEF ≤ 40%
- Referred for RHC for:
- Evaluation for advanced heart failure therapies, including LVAD, OHT, temporary or long-term inotrope therapy, or counter-pulsation (temporary or long-term with NuPulse device OR
- Accurate assessment of invasive hemodynamics due to worsening clinical status, OR
- Assessment of myocardial recovery for consideration of LVAD or counter-pulsation (temporary IABP or long-term with NuPulse device) decommissioning or removal OR
- Assessment of cardiac function and valvular abnormalities prior to planned valvular surgery for MR or AI
- Estimated glomerular filtration rate (eGFR) ≥ 30 ml/min/1.73 m2
- Age ≥ 18 years-old
- Intent for admission based on RHC data
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University Of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.